Immune Checkpoint Inhibitor-Induced Myocarditis vs. COVID-19 Vaccine-Induced Myocarditis—Same or Different?

Immune checkpoint inhibitor (ICI) and coronavirus disease 2019 (COVID-19) vaccine-induced myocarditis possibly share common mechanisms secondary to overactivation of the immune system. We aimed to compare the presenting characteristics of ICIs and COVID-19 vaccine-induced myocarditis. We performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zornitzki, Lior, Havakuk, Ofer, Rozenbaum, Zach, Viskin, Dana, Arbel, Yaron, Flint, Nir, Arnold, Joshua, Waissengein, Barliz, Wolf, Ido, Banai, Shmuel, Topilsky, Yan, Laufer-Perl, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501423/
https://www.ncbi.nlm.nih.gov/pubmed/36143403
http://dx.doi.org/10.3390/life12091366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501423/
https://www.ncbi.nlm.nih.gov/pubmed/36143403
http://dx.doi.org/10.3390/life12091366

Ejemplares similares